Literature DB >> 21355575

Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry.

Kedar G Patel1, James R Swartz.   

Abstract

We present a cell-free protein synthesis (CFPS) platform and a one-step, direct conjugation scheme for producing virus-like particle (VLP) assemblies that display multiple ligands including proteins, nucleic acids, and other molecules. Using a global methionine replacement approach, we produced bacteriophage MS2 and bacteriophage Qβ VLPs with surface-exposed methionine analogues (azidohomoalanine and homopropargylglycine) containing azide and alkyne side chains. CFPS enabled the production of VLPs with yields of ~ 300 μg/mL and with 85% incorporation of methionine analogues without requiring a methionine auxotrophic production host. We then directly conjugated azide- and alkyne-containing proteins (including an antibody fragment and the granulocyte-macrophage colony stimulating factor, or GM-CSF), nucleic acids and poly(ethylene glycol) chains to the VLP surface using Cu(I) catalyzed click chemistry. The GM-CSF protein, after conjugation to VLPs, was shown to partially retain its ability to stimulate the proliferation of cells. Conjugation of GM-CSF to VLPs resulted in a 3-5-fold reduction in its bioactivity. The direct attachment scheme facilitated conjugation of three different ligands to the VLPs in a single step, and enabled control of the relative ratios and surface abundance of the attached species. This platform can be used for the production of novel VLP bioconjugates for use as drug delivery vehicles, diagnostics, and vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355575      PMCID: PMC5437849          DOI: 10.1021/bc100367u

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  58 in total

Review 1.  Virus-like particles as vaccines and vessels for the delivery of small molecules.

Authors:  Robert L Garcea; Lutz Gissmann
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

2.  Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.

Authors:  Gregory Kanter; Junhao Yang; Alexei Voloshin; Shoshana Levy; James R Swartz; Ronald Levy
Journal:  Blood       Date:  2006-12-12       Impact factor: 22.113

Review 3.  The coming of age of virus-like particle vaccines.

Authors:  Gary T Jennings; Martin F Bachmann
Journal:  Biol Chem       Date:  2008-05       Impact factor: 3.915

4.  Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.

Authors:  Junhao Yang; Gregory Kanter; Alexei Voloshin; Nathalie Michel-Reydellet; Hendrik Velkeen; Ronald Levy; James R Swartz
Journal:  Biotechnol Bioeng       Date:  2005-03-05       Impact factor: 4.530

5.  Processing of N-terminal unnatural amino acids in recombinant human interferon-beta in Escherichia coli.

Authors:  Aijun Wang; Natalie Winblade Nairn; Richard S Johnson; David A Tirrell; Kenneth Grabstein
Journal:  Chembiochem       Date:  2008-01-25       Impact factor: 3.164

6.  The refined structure of bacteriophage MS2 at 2.8 A resolution.

Authors:  R Golmohammadi; K Valegård; K Fridborg; L Liljas
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

7.  Viral capsids as MRI contrast agents.

Authors:  Lars Liepold; Stasia Anderson; Deborah Willits; Luke Oltrogge; Joseph A Frank; Trevor Douglas; Mark Young
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

8.  Cell-free production of Gaussia princeps luciferase--antibody fragment bioconjugates for ex vivo detection of tumor cells.

Authors:  Kedar G Patel; Patrick P Ng; Chiung-Chi Kuo; Shoshana Levy; Ronald Levy; James R Swartz
Journal:  Biochem Biophys Res Commun       Date:  2009-10-21       Impact factor: 3.575

9.  Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.

Authors:  M S Kaminski; K Kitamura; D G Maloney; R Levy
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

10.  Interior surface modification of bacteriophage MS2.

Authors:  Jacob M Hooker; Ernest W Kovacs; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2004-03-31       Impact factor: 15.419

View more
  45 in total

1.  Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.

Authors:  Yuan Lu; Wei Chan; Benjamin Y Ko; Christopher C VanLang; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

Review 2.  Cell-free protein synthesis: applications come of age.

Authors:  Erik D Carlson; Rui Gan; C Eric Hodgman; Michael C Jewett
Journal:  Biotechnol Adv       Date:  2011-10-08       Impact factor: 14.227

3.  A Simple RNA-DNA Scaffold Templates the Assembly of Monofunctional Virus-Like Particles.

Authors:  Rees F Garmann; Richard Sportsman; Christian Beren; Vinothan N Manoharan; Charles M Knobler; William M Gelbart
Journal:  J Am Chem Soc       Date:  2015-06-10       Impact factor: 15.419

Review 4.  Nanoscale assemblies and their biomedical applications.

Authors:  Tais A P F Doll; Senthilkumar Raman; Raja Dey; Peter Burkhard
Journal:  J R Soc Interface       Date:  2013-01-09       Impact factor: 4.118

5.  Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging.

Authors:  Makan Khoshnejad; Colin F Greineder; Katherine W Pulsipher; Carlos H Villa; Burcin Altun; Daniel C Pan; Andrew Tsourkas; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  Bioconjug Chem       Date:  2018-02-19       Impact factor: 4.774

6.  Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.

Authors:  Wujin Sun; Yue Lu; Zhen Gu
Journal:  Part Part Syst Charact       Date:  2014-10-16       Impact factor: 3.310

Review 7.  Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting.

Authors:  Makan Khoshnejad; Hamideh Parhiz; Vladimir V Shuvaev; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2018-03-06       Impact factor: 9.776

Review 8.  Vaccine design: emerging concepts and renewed optimism.

Authors:  Sebastian K Grimm; Margaret E Ackerman
Journal:  Curr Opin Biotechnol       Date:  2013-03-07       Impact factor: 9.740

Review 9.  Engineering virus-like particles as vaccine platforms.

Authors:  Kathryn M Frietze; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2016-03-29       Impact factor: 7.090

10.  Site-specific fatty acid-conjugation to prolong protein half-life in vivo.

Authors:  Sung In Lim; Yukina Mizuta; Akinori Takasu; Young S Hahn; Yong Hwan Kim; Inchan Kwon
Journal:  J Control Release       Date:  2013-06-02       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.